EVMN · NYSE · Biotechnology

Evommune (EVMN)

Develops chronic-inflammation therapies centered on EVO756 and EVO301 clinical programs.

$9.70
After-hours close+0.11 (+1.15%)
At close$9.59(+1.48%)